New Study Shows Pepaxti is Safe and Effective for Multiple Myeloma Patients with Kidney Problems
Oncopeptides, a pharmaceutical company, has shared new findings from a clinical trial that show the drug Pepaxti can be safely […]
Pharmaceutical News
Pharmaceutical News
Major Diabetes Drug Maker Sues Over Alleged $200 Million Fraud Scheme Involving Mail-Order Pharmacies and Church-Affiliated Groups
A large pharmaceutical company, Eli Lilly, has filed a lawsuit in Miami accusing several businesses and individuals of defrauding them
Major Italian Pharmaceutical Company May Be Sold to Private Investors
One of Italy’s largest pharmaceutical companies that is publicly traded (meaning its shares are sold on the stock market) may
Pharmaceutical News
Recent Updates in the Pharmaceutical World: New Treatments, Legal Cases, and Market Trends
This week in the pharmaceutical industry, there have been several important developments that may impact patients, healthcare providers, and drug
Pharmaceutical News
New research could make diabetes and obesity medications easier to take by mouth
A recent study led by researchers at Yoon et al. suggests that adding a natural compound called sodium caprate (C10)
New Clinical Trial Begins for Advanced Multiple Myeloma Treatment in Australia
HaemaLogiX, an Australian biotechnology company, has started enrolling patients in a new clinical trial called the Koala study at the
Pharmaceutical News
New AI Technology to Speed Up Development of Parkinson’s Treatment, Partners with Novo Nordisk
A biotechnology company called Cellular Intelligence is using artificial intelligence (AI) to help develop a new type of therapy for
Pharmaceutical News
Pharmacy Experts Urge FDA to Appoint Dr. Richard Pazdur as Next Commissioner
Dr. Richard Pazdur, a highly respected leader with 26 years of experience at the U.S. Food and Drug Administration (FDA),
Pharmaceutical News
Supreme Court Temporarily Allows Telehealth Access to Abortion Pill Mifepristone
The U.S. Supreme Court has temporarily blocked a federal appeals court ruling in Louisiana that would have stopped doctors from
Pharmaceutical News
Eisai Expects Alzheimer’s Drug Leqembi Sales to Grow to $900 Million in 2026, Thanks to Innovations in Diagnosis and Treatment Delivery
Eisai, the company that makes the Alzheimer’s drug Leqembi, expects its sales to nearly double next year, reaching about $900